About Vanquest Pharma
Vanquest Pharma is a Healthcare company. API manufacturing and regulatory services in the healthcare sector. The company has 134 employees. Its Indian entity Vanquest Pharma Private Limited reported revenue of ₹39.34 Cr. Vanquest Pharma offers products and services including APIs and Regulatory Services. Its focus areas include Services, International Marketing, Regulatory Approvals and Pharmaceuticals.
Company details
A facility for manufacturing active pharmaceutical ingredients is operated by Vanquest Pharma at Boisar, located 100 kilometers from Mumbai, spanning 10,500 square meters with world-class infrastructure that complies with requirements of regulated and semi-regulated markets. The company is recognized for its values, including an apolitical workplace, equal opportunities, respect, transparency, and zero tolerance for unethical practices. Efforts are made to leverage experience in international marketing and scientific documentation to secure regulatory approvals, thereby facilitating global business inroads. The vision emphasizes being a trusted provider of quality APIs at affordable costs.
- Employees 134
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Legal Name Vanquest Pharma Private Limited
- Date of Incorporation 12 Jun, 2019
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹39.34 Cr
FY 2025 · -15% YoY
- Indian entity net loss-₹29.48 Cr
FY 2025 · -75% margin
- Indian entity EBITDA-₹11.17 Cr
FY 2025 · -28% margin
- Employee Count134
Associated legal entities of Vanquest Pharma
Vanquest Pharma operates through Vanquest Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Vanquest Pharma Private Limited CIN U24304MH2019PTC326607 | Active | 12 Jun 2019 | Mumbai, Maharashtra | ₹39.3 Cr | 134 | 6 | View details |
Products & Services of Vanquest Pharma
Vanquest Pharma offers a comprehensive portfolio of products and services, including APIs and Regulatory Services.
Active pharmaceutical ingredients are manufactured by Vanquest Pharma to meet the needs of regulated and semi-regulated markets.
Scientific documentation and regulatory approvals are provided by Vanquest Pharma to support international marketing efforts.
Board of directors of Vanquest Pharma Private Limited (Vanquest Pharma)
Vanquest Pharma Private Limited is the primary company behind Vanquest Pharma. The board of Vanquest Pharma Private Limited currently have 6 directors; the longest-serving is Pavan H Patel, appointed in 2019. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pavan H Patel DIN 03439561 | Director | 12 Jun 2019 | 7 yrs 4 mo | Vanquest Pharma Private Limited |
| Hiten Patel DIN 01212873 | Director | 12 Jun 2019 | 7 yrs 4 mo | Vanquest Pharma Private Limited |
| Manish Babulal Jain DIN 01538004 | Director | 12 Jun 2019 | 7 yrs 4 mo | Vanquest Pharma Private Limited |
| Mohan Babulal Jain DIN 00054461 | Director | 12 Jun 2019 | 7 yrs 4 mo | Vanquest Pharma Private Limited |
| Pratik Hitenkumar Patel DIN 03369116 | Director | 12 Jun 2019 | 7 yrs 4 mo | Vanquest Pharma Private Limited |
| Aarya Mohan Jain DIN 11000730 | Additional Director | 26 Mar 2025 | 1 yr 7 mo | Vanquest Pharma Private Limited |
Financials of Vanquest Pharma
Figures of Vanquest Pharma Private Limited, the primary company behind Vanquest Pharma, for FY 2025. Revenue was ₹39.34 Cr (-15% year on year). Net loss was -₹29.48 Cr (-75% margin). EBITDA was -₹11.17 Cr (-28% margin). Revenue has grown at a compounded annual rate of +542% over three years.
- ₹39.34 CrRevenue · FY 2025 · -15% YoY
- -₹29.48 CrNet loss · -75% margin
- -₹11.17 CrEBITDA · -28% margin
- ₹1.00 CrPaid-up capital
- 134Employees (provident fund records)
- +542%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Vanquest Pharma Private Limited are on its company page.
Detailed financial statements for Vanquest Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Vanquest Pharma
Vanquest Pharma has 134 employees.
The primary company behind Vanquest Pharma, Vanquest Pharma Private Limited, reported revenue of ₹39.34 Cr for FY 2025, down 15% year on year.
A facility for manufacturing active pharmaceutical ingredients is operated by Vanquest Pharma at Boisar, located 100 kilometers from Mumbai, spanning 10,500 square meters with world-class infrastructure that complies with requirements of regulated and semi-regulated markets. The company is recognized for its values, including an apolitical workplace, equal opportunities, respect, transparency, and zero tolerance for unethical practices. Efforts are made to leverage experience in international marketing and scientific documentation to secure regulatory approvals, thereby facilitating global business inroads. The vision emphasizes being a trusted provider of quality APIs at affordable costs.
Vanquest Pharma offers APIs and Regulatory Services.
Vanquest Pharma operates through Vanquest Pharma Private Limited.
The legal entities of Vanquest Pharma currently have 6 directors, including Pavan H Patel, Hiten Patel, Manish Babulal Jain and others.